Published in AIDS Weekly, May 16th, 2005
The extension results from Par's recent submission, at the FDA's request, of existing supplemental data on Megace ES. In accordance with FDA regulations, the new PDUFA goal date has been extended three months to July 29, 2005. Following discussions with the FDA, Par believes that the agency may complete its review of Megace ES prior to the new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.